日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TRAIL apoptotic pathway-targeted therapies for NSCLC

TRAIL凋亡通路靶向疗法治疗非小细胞肺癌

Bellail, Anita C; Hao, Chunhai

Therapeutic potential and molecular mechanism of a novel, potent, nonpeptide, Smac mimetic SM-164 in combination with TRAIL for cancer treatment.

一种新型、强效的非肽类 Smac 模拟物 SM-164 与 TRAIL 联合用于癌症治疗的治疗潜力和分子机制

Lu Jianfeng, McEachern Donna, Sun Haiying, Bai Longchuan, Peng Yuefeng, Qiu Su, Miller Rebecca, Liao Jinhui, Yi Han, Liu Meilan, Bellail Anita, Hao Chunhai, Sun Shi-Yong, Ting Adrian T, Wang Shaomeng

Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-regulation of DR5 and down-regulation of c-FLIP

顺铂通过上调DR5和下调c-FLIP来恢复胶质母细胞瘤来源干细胞中的TRAIL凋亡通路。

Ding, Lijuan; Yuan, Changji; Wei, Feng; Wang, Guangyi; Zhang, Jing; Bellail, Anita C; Zhang, Zhaobin; Olson, Jeffrey J; Hao, Chunhai

Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.

人类星形胶质细胞对 Fas 配体和肿瘤坏死因子相关凋亡诱导配体诱导的细胞凋亡具有抵抗力

Song Jin H, Bellail Anita, Tse Margaret C L, Yong V Wee, Hao Chunhai